Yi-Jun Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yi-Jun Wu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Jun Pan
Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 shared publications- Qing Xia
Geriatric Medicine Center, Department of Geriatric Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China
2 shared publications Xiao-Long Du
Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 shared publicationsShuai Dong
Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China
1 shared publication- Shuai Dong
Department of Thyroid Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China
1 shared publication Xiao-Jun Xie
Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication
Latest Publications
- 19 March 2024
- Published by Springer Nature in Endocrine
- Vol. 85 (2) , 1-8
Prediction of bilateral thyroid carcinoma and lateral cervical lymph node metastasis in PTC patients with suspicious thyroid nodules
Purpose This study aimed to evaluate the factors associated with bilateral papillary thyroid carcinoma (PTC) and lateral cervical lymph node metastasis (LLNM) in patients with suspicious unilateral PTC. Methods This study analyzed patients with suspicious unilateral PTC who were enrolled in a university hospital between 2016 and 2019 in Zhejiang, China. Using logistic regression, the study examined the factors associated with bilateral PTC and LLNM in demographic data, anthropometric measurements, lifestyle factors, medical history, preoperative diagnostic tests, and histopathological factors. Results A total of 256 patients, with a mean age of 49 years, were enrolled. Bilateral PTC was associated with multifocality (aOR: 5.069, 95% CI: 2.440–10.529, P < 0.001), and contralateral nodule in the upper (aOR: 9.073, 95% CI: 2.111–38.985, P = 0.003) and middle (aOR: 9.926, 95% CI: 2.683–36.717, P < 0.001). LLNM was positively associated with bilateral PTC (aOR, 4.283, 95% CI: 1.378–13.308, p = 0.012), male (aOR, 3.377, 95% CI: 1.205–9.461, P = 0.021), upper location of carcinoma (aOR, 3.311, 95% CI: 1.091–10.053, p = 0.035), and punctate echogenic foci (aOR, 3.309, 95% CI: 1.165–9.394, P = 0.025). Contralateral maximal nodule in the upper (aOR: 0.098, 95% CI: 0.015–0.628, p = 0.014), middle (aOR: 0.114, 95% CI: 0.033–0.522, p < 0.001), and lower (aOR, 0.028, 95% CI: 0.003–0.276, P = 0.002) location were inversely associated with LLNM. Conclusion Upper and middle location of contralateral nodule and tumor multifocality predicted the risk bilateral PTC. Bilateral PTC, male, upper tumor location, punctate echogenic foci and contralateral nodule location in the entire lobes were independent predictors for LLNM.
- 19 March 2024
- Published by Springer Nature in Endocrine
- Vol. 85 (2) , 1-8
Prediction of bilateral thyroid carcinoma and lateral cervical lymph node metastasis in PTC patients with suspicious thyroid nodules
Purpose This study aimed to evaluate the factors associated with bilateral papillary thyroid carcinoma (PTC) and lateral cervical lymph node metastasis (LLNM) in patients with suspicious unilateral PTC. Methods This study analyzed patients with suspicious unilateral PTC who were enrolled in a university hospital between 2016 and 2019 in Zhejiang, China. Using logistic regression, the study examined the factors associated with bilateral PTC and LLNM in demographic data, anthropometric measurements, lifestyle factors, medical history, preoperative diagnostic tests, and histopathological factors. Results A total of 256 patients, with a mean age of 49 years, were enrolled. Bilateral PTC was associated with multifocality (aOR: 5.069, 95% CI: 2.440–10.529, P < 0.001), and contralateral nodule in the upper (aOR: 9.073, 95% CI: 2.111–38.985, P = 0.003) and middle (aOR: 9.926, 95% CI: 2.683–36.717, P < 0.001). LLNM was positively associated with bilateral PTC (aOR, 4.283, 95% CI: 1.378–13.308, p = 0.012), male (aOR, 3.377, 95% CI: 1.205–9.461, P = 0.021), upper location of carcinoma (aOR, 3.311, 95% CI: 1.091–10.053, p = 0.035), and punctate echogenic foci (aOR, 3.309, 95% CI: 1.165–9.394, P = 0.025). Contralateral maximal nodule in the upper (aOR: 0.098, 95% CI: 0.015–0.628, p = 0.014), middle (aOR: 0.114, 95% CI: 0.033–0.522, p < 0.001), and lower (aOR, 0.028, 95% CI: 0.003–0.276, P = 0.002) location were inversely associated with LLNM. Conclusion Upper and middle location of contralateral nodule and tumor multifocality predicted the risk bilateral PTC. Bilateral PTC, male, upper tumor location, punctate echogenic foci and contralateral nodule location in the entire lobes were independent predictors for LLNM.
- Open Access
- 1 November 2023
- Published by Taylor & Francis in Nanomedicine
- Vol. 18 (27) , 2039-2059
Hyperbranched Polyamidoamine–RGD Peptide/si- circICA1 in the Treatment of Invasive Thyroid Cancer through Targeting of the miR-486-3p /SERPINA1 Axis
Aim: This study aimed to identify molecular markers associated with papillary thyroid cancer (PTC) and investigate the therapeutic potential of targeted nanoscale drugs. Materials & methods: We ana... Graphical abstract
- 1 November 2023
- Published by Taylor & Francis in Nanomedicine
- Vol. 18 (27) , 2039-2059
Open AccessHyperbranched Polyamidoamine–RGD Peptide/si- circICA1 in the Treatment of Invasive Thyroid Cancer through Targeting of the miR-486-3p /SERPINA1 Axis
Aim: This study aimed to identify molecular markers associated with papillary thyroid cancer (PTC) and investigate the therapeutic potential of targeted nanoscale drugs. Materials & methods: We ana... Graphical abstract